Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Disc Medicine, Inc. - Common Stock
(NQ:
IRON
)
29.00
+0.47 (+1.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
276,189
Open
28.78
Bid (Size)
28.97 (16)
Ask (Size)
29.01 (4)
Prev. Close
28.53
Today's Range
28.40 - 29.77
52wk Range
25.60 - 77.60
Shares Outstanding
5,000,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Top 3 Health Care Stocks You'll Regret Missing This Month
April 02, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Gold Gains 1%; CXApp Shares Spike Higher
April 01, 2024
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Monday. The Dow traded down 0.67% to 39,538.91 while the NASDAQ fell 0.06% to 16,369.44. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
-51.45%
-51.45%
1 Month
-15.23%
-15.23%
3 Month
-55.89%
-55.89%
6 Month
-36.94%
-36.94%
1 Year
-11.04%
-11.04%
More News
Read More
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 01, 2024
Via
Benzinga
NASDAQ:IRON Shareholder Notice: Investigation over Potential Wrongdoing at Disc Medicine Opco Inc
December 08, 2023
Via
SBWire
Crude Oil Moves Higher; Oxford Industries Shares Fall After Q4 Results
April 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
April 01, 2024
Via
Benzinga
Disc Medicine Stock Plunges As Light Sensitivity Treatment Data Confounded Due To Outsized Placebo Response
April 01, 2024
Via
Benzinga
Disc Medicine Plummets 59% After Placebo Effect Confounds Sunlight Sensitivity Study
April 01, 2024
Via
Investor's Business Daily
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
April 01, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 21, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
March 06, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal
March 02, 2024
Via
Talk Markets
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
February 26, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
February 20, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
February 09, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
February 07, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board
December 20, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Blue Bird Posts Upbeat Results, Joins Oil-Dri Corporation of America, Eagle Bulk Shipping And Other Big Stocks Moving Higher On Tuesday
December 12, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting
December 11, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting
December 11, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin
November 14, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Participate in Upcoming Investor Conferences
November 08, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates
November 02, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.